Oyster Point Pharma Strengthens Executive Leadership Team with the Appointment of Chief Medical and Chief Scientific Officers

Author's Avatar
Dec 07, 2020
Article's Main Image

Industry veterans in ophthalmology will lead and expand the company’s R&D and clinical efforts